相关实验视频

Updated: May 27, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

中美洲和加勒比地区对MS,NMOSD和MOGAD治疗的共识

Deyanira A Ramirez¹, Fernando Gracia², Alejandro J Diaz Jimenez³

¹Servicio de Neurología, Hospital Padre Billini, Santo Domingo, Dominican Republic.

Multiple sclerosis and related disorders

|February 15, 2025

概括

这一共识为管理多发性硬化症 (MS),神经omyelitis光学谱障碍 (NMOSD) 和拉丁美洲的MOGAD等免疫脱髓化疾病提供了最新的指导方针,解决了社会经济挑战和治疗策略.

科学领域:

神经免疫学神经免疫学
神经学神经学
临床实践指南临床实践指南

背景情况:

在诊断和治疗免疫脱髓化疾病方面的进展是显著的.
拉丁美洲的社会经济因素给疾病管理带来了挑战.
需要根据区域背景定制更新的临床指导方针.

研究的目的:

更新管理多发性硬化症 (MS),神经髓炎光学谱障碍 (NMOSD) 和MOGAD的共识指南.
为将可用的治疗方法纳入临床实践提供一个框架.
为应对中美洲和加勒比地区的挑战.

主要方法:

进行了广泛的文献搜索.
论坛成员参与的共识过程.
编写一份经过修订并最终完成的报告.

主要成果:

共识涵盖疾病修饰药物 (DMD),生物剂和葡萄皮质皮质激素.
包括治疗失败,患者监测和治疗停止的定义.
针对怀孕/哺乳期治疗和疫苗接种策略.

结论:

修订后的指导方针旨在改善免疫脱髓化疾病的长期结果.
支持患者,监管机构,医疗保健提供者和决策者.
在资源有限的环境中增强管理策略.

关键词:

中美洲和加勒比地区.达成共识达成共识莫加德 - 莫加德在MSMSMSMSMSMSMSMSMSMSMS中,我们可以看到这是NMOSD的NMOSD.治疗方法治疗方法

更多相关视频

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

相关概念视频

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...